Pulmonary Hypertension with Lung Disease
by Kevin Smith Business Information.Brief
description of study
Researchers at the University of Kentucky are conducting a study
to investigate the safety and how well the inhaled investigational drug
treprostinil works in people with pulmonary hypertension associated with lung
disease. This study will look at your ability to exercise after taking the
study drug.
You may be eligible to participate if you:
-Are 18 years of age or older;
-Do not have a history of drug abuse;
-Are able to walk for 6-minutes; and
-Do not have diabetes.
Participants will be compensated for your time.
For more information, please contact:
Ketan Buch, MD
kpbuch0@uky.edu
or
Research coordinator:
859-218-6740
Sponsor Ads
Created on Jan 10th 2019 00:17. Viewed 347 times.
Comments
No comment, be the first to comment.